Back to Search Start Over

MicroRNA-23b downregulates peroxiredoxin III in human prostate cancer.

Authors :
He HC
Zhu JG
Chen XB
Chen SM
Han ZD
Dai QS
Ling XH
Fu X
Lin ZY
Deng YH
Qin GQ
Cai C
Chen JH
Zhong WD
Source :
FEBS letters [FEBS Lett] 2012 Jul 30; Vol. 586 (16), pp. 2451-8. Date of Electronic Publication: 2012 Jun 16.
Publication Year :
2012

Abstract

To investigate the mechanism by which peroxiredoxin III (PRDX3) is altered in human prostate cancer (PCa), we used microRNA (miRNA) target prediction program and miRNA microarray to predict and identify miR-23b as a candidate miRNA that targets PRDX3. We showed that miR-23b suppresses PRDX3 protein expression in human DU145 cells under normal and hypoxic conditions. Additionally, the clinical significance of miR-23b and PRDX3 expression in PCa patients was also confirmed. In conclusion, our data suggest that the effects of PRDX3 in PCa progression may be caused by the regulation function of miR-23b, and consequently, miR-23b may be involved in the response of PCa cells to hypoxia stress.<br /> (Crown Copyright © 2012. Published by Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1873-3468
Volume :
586
Issue :
16
Database :
MEDLINE
Journal :
FEBS letters
Publication Type :
Academic Journal
Accession number :
22710126
Full Text :
https://doi.org/10.1016/j.febslet.2012.06.003